As of Jan 13
| -0.01 / -0.16%|
The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +254.89% increase from the last price of 6.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.